Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Ovarian Neoplasms

  Free Subscription


12.11.2018

1 Am J Clin Pathol
1 BMC Cancer
1 Cancer Res
7 Gynecol Oncol
1 Lancet Oncol
1 Obstet Gynecol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Clin Pathol

  1. NISHIKIMI K, Nakagawa K, Tate S, Matsuoka A, et al
    Uncommon Human Telomerase Reverse Transcriptase Promoter Mutations Are Associated With Poor Survival in Ovarian Clear Cell Carcinoma.
    Am J Clin Pathol. 2018;149:352-361.
    PubMed     Text format     Abstract available


    BMC Cancer

  2. YOSHIMURA A, Sawada K, Nakamura K, Kinose Y, et al
    Exosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in neighboring peritoneal mesothelial cells.
    BMC Cancer. 2018;18:1065.
    PubMed     Text format     Abstract available


    Cancer Res

  3. LU Y, Hu Z, Mangala LS, Stine ZE, et al
    MYC Targeted Long Noncoding RNA DANCR Promotes Cancer in Part by Reducing p21 Levels.
    Cancer Res. 2018;78:64-74.
    PubMed     Text format     Abstract available


    Gynecol Oncol

  4. MATSUOKA A, Tate S, Nishikimi K, Shozu M, et al
    Successful retroperitoneal lymphadenectomy for double inferior vena cava with preoperative assessment using contrast-enhanced and three-dimensional computed tomography.
    Gynecol Oncol. 2018;151:180-181.
    PubMed     Text format    

  5. PERES LC, Cushing-Haugen KL, Anglesio M, Wicklund K, et al
    Histotype classification of ovarian carcinoma: A comparison of approaches.
    Gynecol Oncol. 2018 Aug 15. pii: S0090-8258(18)31133.
    PubMed     Text format     Abstract available

  6. LYCKE M, Kristjansdottir B, Sundfeldt K
    A multicenter clinical trial validating the performance of HE4, CA125, risk of ovarian malignancy algorithm and risk of malignancy index.
    Gynecol Oncol. 2018 Aug 24. pii: S0090-8258(18)31155.
    PubMed     Text format     Abstract available

  7. VAN NIEUWENHUYSEN E, Busschaert P, Neven P, Han SN, et al
    The genetic landscape of 87 ovarian germ cell tumors.
    Gynecol Oncol. 2018 Aug 28. pii: S0090-8258(18)31130.
    PubMed     Text format     Abstract available

  8. MULLEN MM, Kuroki LM, Thaker PH
    Novel treatment options in platinum-sensitive recurrent ovarian cancer: A review.
    Gynecol Oncol. 2018 Nov 5. pii: S0090-8258(18)31306.
    PubMed     Text format     Abstract available

  9. LEE JY, Park JY, Park SY, Lee JW, et al
    Real-world effectiveness of bevacizumab based on AURELIA in platinum-resistant recurrent ovarian cancer (REBECA): A Korean Gynecologic Oncology Group study (KGOG 3041).
    Gynecol Oncol. 2018 Nov 5. pii: S0090-8258(18)31314.
    PubMed     Text format     Abstract available

  10. ZHONG Q, Hu Z, Li Q, Yi T, et al
    Cyclin D1 silencing impairs DNA double strand break repair, sensitizes BRCA1 wildtype ovarian cancer cells to olaparib.
    Gynecol Oncol. 2018 Nov 7. pii: S0090-8258(18)31310.
    PubMed     Text format     Abstract available


    Lancet Oncol

  11. FAGOTTI A, Scambia G
    Neoadjuvant chemotherapy versus upfront debulking surgery in advanced tubo-ovarian cancer.
    Lancet Oncol. 2018 Nov 6. pii: S1470-2045(18)30625.
    PubMed     Text format    


    Obstet Gynecol

  12. WRIGHT JD
    What Is New in Ovarian Cancer?: Best Articles From the Past Year.
    Obstet Gynecol. 2018 Nov 5. doi: 10.1097/AOG.0000000000002989.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ovarian Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: